In terms of the treatment modality of diabetes, the aOR (95% CI) was lowest in the oral hypoglycemic agent group (1.47 (1.08–2.01)) and highest in the insulin group (6.63 (3.04–14.44)) compared to the no diabetes group. The gene discussed is INS; the disease is diabetes mellitus.